Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Vitamin Shoppe Company Profile (NYSE:VSI)

Consensus Ratings for Vitamin Shoppe (NYSE:VSI) (?)
Ratings Breakdown: 1 Sell Rating(s), 7 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $45.09 (11.94% upside)

Current Analysts' Coverage Summary for Vitamin Shoppe (NYSE:VSI)
Show:
DateFirmActionRatingPrice TargetActions
5/7/2015BarclaysSet Price TargetEqual Weight$45.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Jefferies GroupReiterated RatingHold$44.00 -> $43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Piper JaffrayReiterated RatingIn-Line$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Deutsche BankReiterated RatingHold$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015Bank of AmericaDowngradeNeutral -> Underperform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014StephensInitiated CoverageOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Goldman SachsDowngradeBuy -> Neutral$49.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2014WedbushDowngradeOutperform -> Neutral$50.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2014Sterne Agee CRTDowngradeBuy -> Neutral$53.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/19/2014Morgan StanleyReiterated RatingOverweight$49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2014JPMorgan Chase & Co.Reiterated RatingOverweight$54.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2014Longbow ResearchReiterated RatingBuy$59.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/23/2014William BlairDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/1/2013Buckingham ResearchInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2013Credit SuisseDowngradeOutperform -> Neutral$55.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013SusquehannaSet Price TargetPositive$67.00 -> $59.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2013 forward)